**Confidential Acquisition Opportunity: Multi-Asset Health & Wellness Innovation Platform**

Rare opportunity to acquire a differentiated health, nutrition and wellness company combining proprietary bioactive intellectual property, human clinical research, an established consumer-health brand, functional food and beverage applications, digital wellness commercialization rights and an additional pre-commercial bioactive IP program.

This is substantially more than a traditional supplement brand.

The company has invested significant capital and years of development into building a multi-asset platform designed to commercialize proprietary health and nutrition innovation across both B2B and B2C channels.

At the center of the opportunity is a naturally derived, clinically studied proprietary bioactive platform protected by issued intellectual property across multiple major international markets. The platform has potential applications across supplements, softgels, gummies, functional foods, beverages and B2B ingredient solutions.

The acquisition also includes an established consumer-health brand with developed products, Amazon and direct-to-consumer infrastructure, national and regional retail distribution, trademarks, digital assets, manufacturing and supplier relationships, and an established commercialization foundation.

Beyond the core consumer and ingredient businesses, the company has contractual rights to commercialize a complementary proprietary digital wellness platform, including potential white-label applications for retailers and consumer brands, subject to applicable agreement terms.

An additional pre-commercial bioactive intellectual-property program addressing another significant health category provides further long-term product-development, licensing and partnership optionality beyond the company's core metabolic-health platform.

A strategic or well-capitalized financial acquirer has multiple potential pathways to create value, including:

• B2B proprietary ingredient sales
• Strategic licensing and partnerships
• Consumer-health products
• Amazon and direct-to-consumer growth
• Retail expansion growth
• Functional food applications
• Beverage and liquid formats
• Digital wellness and white-label programs
• International commercialization
• Future bioactive IP development and licensing

Significant foundational work has already been completed across clinical research, intellectual property, formulation, product development, manufacturing, supply chain and commercialization. The business utilizes a capital-efficient outsourced manufacturing model that can potentially be integrated into an acquirer's existing infrastructure.

The opportunity may be particularly attractive to strategic nutrition and ingredient companies, consumer-health platforms, food and beverage companies, digital-health businesses, retailers, private-equity-backed health and wellness companies, family offices and strategic investors.

The shareholders are evaluating strategic alternatives to accelerate commercialization under an organization with greater resources, scale, distribution and access to capital.

**Asking Price: US$7.5 Million**

The seller prefers a 100% acquisition of the company or substantially all operating assets but will consider alternative strategic transaction structures from qualified parties. Seller financing may be considered as part of an appropriate transaction structure.

This is a confidential offering. Company identity, detailed financial information, clinical data, intellectual property, brands, commercial agreements and other proprietary information will be provided to qualified prospective acquirers following execution of a confidentiality agreement.

**Serious inquiries only. Qualified parties will be asked to complete an NDA and buyer profile before receiving confidential information.**